skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 15,903  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Database: Taylor & Francis (Open access) remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid
Material Type:
Article
Add to My Research

First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid

Alexandria journal of medicine, 2018-12, Vol.54 (4), p.287-293 [Peer Reviewed Journal]

2017 Alexandria University Faculty of Medicine ;2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. 2017 ;ISSN: 2090-5068 ;EISSN: 2090-5076 ;DOI: 10.1016/j.ajme.2017.09.001

Full text available

2
Pathophysiology and mechanism of long COVID: a comprehensive review
Material Type:
Article
Add to My Research

Pathophysiology and mechanism of long COVID: a comprehensive review

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.1473-1487 [Peer Reviewed Journal]

2022 Belgian Health Care Knowledge Centre (KCE). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 Belgian Health Care Knowledge Centre (KCE). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 Belgian Health Care Knowledge Centre (KCE) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2076901 ;PMID: 35594336

Full text available

3
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Material Type:
Article
Add to My Research

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.524-540 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2031274 ;PMID: 35132910

Full text available

4
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis
Material Type:
Article
Add to My Research

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.516-523 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2034936 ;PMID: 35118917

Full text available

5
Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis
Material Type:
Article
Add to My Research

Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysis

The European journal of general practice, 2018-01, Vol.24 (1), p.9-18 [Peer Reviewed Journal]

2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 ;2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 The Author(s) ;ISSN: 1381-4788 ;EISSN: 1751-1402 ;DOI: 10.1080/13814788.2017.1375091 ;PMID: 29199486

Full text available

6
Series: Practical guidance to qualitative research. Part 4: Trustworthiness and publishing
Material Type:
Article
Add to My Research

Series: Practical guidance to qualitative research. Part 4: Trustworthiness and publishing

The European journal of general practice, 2018-01, Vol.24 (1), p.120-124 [Peer Reviewed Journal]

2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 ;2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 The Author(s) ;ISSN: 1381-4788 ;EISSN: 1751-1402 ;DOI: 10.1080/13814788.2017.1375092 ;PMID: 29202616

Full text available

7
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
Material Type:
Article
Add to My Research

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid, 2018-10, Vol.25 (4), p.215-219 [Peer Reviewed Journal]

2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;ISSN: 1350-6129 ;ISSN: 1744-2818 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2018.1549825

Digital Resources/Online E-Resources

8
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management
Material Type:
Article
Add to My Research

Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management

Current medical research and opinion, 2019-11, Vol.35 (11), p.2015-2024 [Peer Reviewed Journal]

2019 Boehringer Ingelheim. Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2019.1647040

Digital Resources/Online E-Resources

9
Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6 - March 29, 2021
Material Type:
Article
Add to My Research

Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6 - March 29, 2021

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.1419-1428 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2021.1957998 ;PMID: 34482788

Full text available

10
Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review
Material Type:
Article
Add to My Research

Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review

Current medical research and opinion, 2022-08, Vol.38 (8), p.1391-1399 [Peer Reviewed Journal]

2022 Johnson & Johnson, LLC. Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2022.2081454

Digital Resources/Online E-Resources

11
Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets and in vitro alpha-thrombin-evoked platelet responses
Material Type:
Article
Add to My Research

Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets and in vitro alpha-thrombin-evoked platelet responses

Annals of medicine (Helsinki), 2023-12, Vol.55 (1), p.1102 [Peer Reviewed Journal]

ISSN: 0785-3890 ;ISSN: 1365-2060 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2023.2171108

Full text available

12
Impact of COVID-19 pandemic on routine immunization
Material Type:
Article
Add to My Research

Impact of COVID-19 pandemic on routine immunization

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.2286-2297 [Peer Reviewed Journal]

2021 GlaxoSmithKline Biologicals S.A. Published by Informa UK Limited, trading as Taylor & Francis Group 2021 ;2021 GlaxoSmithKline Biologicals S.A. Published by Informa UK Limited, trading as Taylor & Francis Group 2021 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2021.2009128 ;PMID: 34854789

Full text available

13
Validation of the 2011 and 2016 American college of rheumatology diagnostic criteria for fibromyalgia in a Chinese population
Material Type:
Article
Add to My Research

Validation of the 2011 and 2016 American college of rheumatology diagnostic criteria for fibromyalgia in a Chinese population

Annals of medicine (Helsinki), 2023-12, Vol.55 (2), p.2249921-2249921 [Peer Reviewed Journal]

2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2023.2249921 ;PMID: 37634058

Full text available

14
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
Material Type:
Article
Add to My Research

Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Amyloid, 2020-10, Vol.27 (4), p.217-222 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 1350-6129 ;ISSN: 1744-2818 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2020.1835263

Digital Resources/Online E-Resources

15
Understanding modern-day vaccines: what you need to know
Material Type:
Article
Add to My Research

Understanding modern-day vaccines: what you need to know

Annals of medicine (Helsinki), 2018-02, Vol.50 (2), p.110-120 [Peer Reviewed Journal]

2017 GlaxoSmithKline Biologicals S.A. Published by Informa UK Limited, trading as Taylor & Francis Group. 2017 ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2017.1407035

Digital Resources/Online E-Resources

16
Renal complications in COVID-19: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Renal complications in COVID-19: a systematic review and meta-analysis

Annals of medicine (Helsinki), 2020-10, Vol.52 (7), p.345-353 [Peer Reviewed Journal]

2020 Informa UK Limited, trading as Taylor & Francis Group 2020 ;2020 Informa UK Limited, trading as Taylor & Francis Group 2020 Informa UK Limited, trading as Taylor & Francis Group ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2020.1790643 ;PMID: 32643418

Full text available

17
Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Material Type:
Article
Add to My Research

Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.1667-1677 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2083671 ;PMID: 35695557

Full text available

18
The reported effects of the COVID-19 pandemic on people with intellectual disability and their carers: a scoping review
Material Type:
Article
Add to My Research

The reported effects of the COVID-19 pandemic on people with intellectual disability and their carers: a scoping review

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.786-804 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2021.1922743 ;PMID: 34110258

Full text available

19
Influence of gut microbiota on eye diseases: an overview
Material Type:
Article
Add to My Research

Influence of gut microbiota on eye diseases: an overview

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.750-761 [Peer Reviewed Journal]

2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2021.1925150 ;PMID: 34042554

Full text available

20
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
Material Type:
Article
Add to My Research

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

Amyloid, 2023-01, Vol.30 (1), p.18-26 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 1350-6129 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2022.2091985

Digital Resources/Online E-Resources

Results 1 - 20 of 15,903  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1981  (209)
  2. 1981 To 1990  (281)
  3. 1991 To 2001  (483)
  4. 2002 To 2012  (2,948)
  5. After 2012  (11,983)
  6. More options open sub menu

Resource Type 

  1. Articles  (15,889)
  2. Reviews  (13)
  3. Web Resources  (1)
  4. More options open sub menu

Language 

  1. Japanese  (501)
  2. Portuguese  (75)
  3. Norwegian  (42)
  4. Swedish  (1)
  5. More options open sub menu

Searching Remote Databases, Please Wait